Table 1. Main characteristics of the included reviews.
| Author, (year) | No. of included studies [sample size] | Type of included studies | Intervention | Quality assessment tool | Data analysis methods | Sensitivity/subgroup analysis | Results summary | |
|---|---|---|---|---|---|---|---|---|
| Treatment | Control | |||||||
| Clavijo et al. (2017) | 7 [602] | RCT | LI-ESWT | Sham treatment | Cochrane Risk of Bias Assessment tool | Meta-analysis | Yes/no | Effective |
| Zou et al. (2017) | 4 [297] | RCT | LI-ESWT | Sham treatment | Cochrane Collaboration Risk of Bias Tool | Meta-analysis | Yes/yes | Effective |
| Sokolakis et al.(2019) | 10 [873] | RCT | LI-ESWT | Sham treatment | Cochrane Risk of Bias Assessment tool | Meta-analysis | No/yes | Effective |
| Man et al. (2018) | 9 [637] | RCT | LI-ESWT | Sham treatment | Cochrane Risk of Bias Assessment tool | Meta-analysis | No/yes | Effective |
| Lu et al. (2017) | 14 [833] | 7 (RCT); 7 (Cohort study) | LI-ESWT, LI-ESWT + PDE5i | Sham treatment | Cochrane Risk of Bias Assessment tool | Meta-analysis | No/yes | Effective |
| Dong et al. (2019) | 7 [522] | RCT | LI-ESWT, LI-ESWT +PDE5i | Sham therapy with shock wave probes | Cochrane Risk of Bias Assessment tool | Meta-analysis | Yes/yes | Effective |
| Mo et al. (2019) | 8 [595] | RCT | LI-ESWT | Sham treatment | Jadad Score | Meta-analysis | No/no | Effective |
| Liu et al. (2018) | 10 [697] | RCT | LI-ESWT, LI-ESWT + PDE5i | Sham treatment | Cochrane Risk of Bias Assessment tool | Meta-analysis | No/yes | Effective |
RCT, randomized controlled trial; LI-ESWT, low-intensity extracorporeal shockwave therapy; PDE5i, phosphodiesterase type 5 inhibitor.